Selective and controlled expansion of educated NK cells

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 11471486
APP PUB NO 20150224143A1
SERIAL NO

14425614

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates generally to immunotherapy. Disclosed herein are methods for obtaining cytolytic differentiated NKG2A−NKG2C+ cells with a given KIR specificity and also compositions comprising these cells as well as the use of these cells for therapy. The NK cell expansion methods provided herein also have non-therapeutic uses.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • INVEN2 AS

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Beziat, Vivien Huddinge, SE 1 2
Malmberg, Karl-Johan Oslo, NO 2 2

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
3.5 Year Payment $1600.00 $800.00 $400.00 Apr 18, 2026
7.5 Year Payment $3600.00 $1800.00 $900.00 Apr 18, 2030
11.5 Year Payment $7400.00 $3700.00 $1850.00 Apr 18, 2034
Fee Large entity fee small entity fee micro entity fee
Surcharge - 3.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00